Funding round for Piomic Medical
Regenerative medical technology · Switzerlandfunding round withSwisscanto
advised by
- Buy-side
- Schellenberg Wittmer
Swisscanto leads the $25m financing round of Piomic Medical as lead investor.
- Lead investor
- Swisscanto
- Target
- Piomic Medical
- Type
- Funding round
- Sector
- Healthcare & Medtech
- Country
- Switzerland
- First reported
- 29/09/2026
- Buy-side
- Schellenberg Wittmer, according to the source
- Source
- Schellenberg Wittmer
Deal-Radar no. 42-052 · added in Week 42/2026, first reported on 29/09/2026 · publicly reported, without guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Transactions by Swisscanto
So far this is the only transaction by Swisscanto published in the Deal-Radar. New deals are added every Monday.
Venture and growth in Week 42/2026
All deals in September 2026Every Monday, all deals of the previous week, with source.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 19 October 2026.